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Abstract
Introduction and hypothesis Pelvic organ prolapse (POP) is a
common condition with multifactorial etiology. The purpose
of this systematic review was to provide an overview of liter-
ature on risk factors for POP and POP recurrence.
Methods PubMed and Embase were searched with Bpelvic
organ prolapse^ combined with Brecurrence^ and combined
with Brisk factors,^ with Medical Subject Headings and The-
saurus terms and text words variations until 4 August 2014,
without language or publication date restrictions. Only cohort
or cross-sectional studies carried out in western developed
countries containing multivariate analyses and with a defini-
tion of POP based on anatomical references were included.
POP recurrence had to be defined as anatomical recurrence
after native tissue repair without mesh. Follow-up after sur-
gery should have been at least 1 year. Articles were excluded if
POP was not a separate entity or if it was unclear whether the
outcome was primary POP or recurrence.
Results PubMed and Embase revealed 2,988 and 4,449 arti-
cles respectively. After preselection, 534 articles were inde-
pendently evaluated by two researchers, of which 15 met the
selection criteria. In 10 articles on primary POP, 30 risk factors
were investigated. Parity, vaginal delivery, age, and bodymass
index (BMI) were significantly associated in at least two arti-
cles. In 5 articles on POP recurrence, 29 risk factors were
investigated. Only preoperative stage was significantly asso-
ciated in at least two articles.
Conclusion Parity, vaginal delivery, age, and BMI are risk
factors for POP and preoperative stage is a risk factor for
POP recurrence.
Keywords Pelvic organ prolapse . Recurrence . Risk factors
Introduction
Female pelvic organ prolapse (POP) is a common condition
that is multifactorial in etiology [1]. It is likely that combina-
tions of anatomical, physiological, genetic, lifestyle, and re-
productive factors interact throughout a woman’s lifespan to
contribute to pelvic floor dysfunction [2]. The factors causing
POP development vary from patient to patient [3]. Unraveling
the complex causal network of genetic factors, birth-induced
injury, connective tissue aging, lifestyle, and co-morbid fac-
tors is challenging [2].
While two thirds of parous women have anatomical evi-
dence of POP [4], the majority of these women are asymp-
tomatic [5]. It has been reported that in a general population
40 % of women aged between 45 and 85 years have an ob-
jective POP on examination, but only 12 % of these women
are symptomatic [6]. Women with symptomatic disorders suf-
fer physical and emotional distress [7]. It has a great negative
impact on women’s social, physical, and psychological well-
being [8]. As the general population ages, pelvic floor dys-
function will become increasingly burdensome in terms of
reduced quality of life, workforce productivity, and cost to
both the individual and the health care system as a whole [9].
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The lifetime risk of surgery for POP in the general female
population is 11.1 % [10]. Surgery for POP is known to have a
high reoperation rate [10]. The identification of risk factors for
POP development and its recurrence therefore appears crucial
for the best management of women with this condition to
provide proper preoperative counseling or modulate patients’
expectations and tailor surgical treatment [11].
An overview of the literature on risk factors for POP and its
recurrence after native tissue repair would help to build a risk
model to identify low- and high-risk women. The purpose of
this systematic review was to provide an overview of the pub-
lished literature on risk factors for the development of POP
and its recurrence after native tissue repair.
Materials and methods
The primary investigator (TFMV) and a clinical librarian
searched the electronic databases PubMed and Embase with
the search terms Bpelvic organ prolapse^ in combination with
Brecurrence,^ and Bpelvic organ prolapse^ in combination
with Brisk factors^ from inception until 4 August 2014. To
capture all relevant articles on this subject, Medical Subject
Headings (MeSH) and Thesaurus terms and text words with
different word variations were used. Restrictions on publica-
tion date or language were not applied. The searches are
depicted in the Appendices A1 and A2.
At first, all studies were evaluated by title. Of the papers
available, those titles were selected that might contain infor-
mation about risk factors for primary POP or POP recurrence.
After this preselection, two researchers (TFMV and MW)
independently evaluated all studies by abstract. If there was
disagreement, full-text articles were evaluated. If the full text
was unavailable, authors were contacted to obtain the article.
Abstracts were included in case they reported on clinical stud-
ies on the etiology or risk factors for primary POP or POP
recurrence. Letters, commentaries, and editorial notes were
excluded. The full text of the articles included was assessed
using an in- and exclusion form. Cohort studies or cross-
sectional studies carried out in western developed countries
were included. The definition of POP had to be based on
anatomical references such as the hymenal remnants or the
Pelvic Organ Prolapse Quantification (POPQ) system stage
2. POP recurrence had to be defined as anatomical recurrence
after native tissue repair (i.e., without the use of mesh mate-
rials and follow-up after surgery should at least be 1 year.
Furthermore, articles had to contain a multivariate analysis.
Articles were excluded if they did not study POP as a separate
entity (but investigated pelvic floor dysfunction in general), if
it was unclear whether the outcome was a primary POP or a
POP recurrence (e.g., after hysterectomy) and in case POP
recurrence was studied after mesh augmentation. If there were
more publications using the same study population, only the
most recent study was included. If there was disagreement on
the in- or exclusion of an article after discussion between the
two observers, the decision was made by asking the opinion of
one of the other researchers in the research group (KBK).
A manual search of the references of each selected article
was performed to further identify studies not captured by the
online search, but potentially relevant for this review.
After the final selection, data were extracted on study de-
sign, the aim of the study, sample size, the study population,
the definition of outcome, the risk factors investigated, and the
results of the multivariate analysis. If multiple analyses were
performed with different definitions of POP, data regarding
the definition BPOPQ stage 2 or more^ or closest to this def-
inition, were extracted.
P values <0.05 were considered statistically significant.
Only risk factors that were significantly associated with POP
or POP recurrence in the multivariate analysis in at least two
studies, were defined as confirmed risk factors.
Results
The PubMed search and the Embase search revealed 2,988
and 4,449 articles respectively. After elimination of dupli-
cates, 5,093 articles were evaluated by title and/or abstract.
Full texts of 130 articles were assessed using the in- and ex-
clusion form, of which 15 articles met the selection criteria.
No additional studies were identified by cross-checking refer-
ence lists. Of the 15 articles included in this systematic review,
10 investigated risk factors for primary POP and 5 articles
investigated risk factors for POP recurrence after surgery.
Figure 1 shows the flow diagram of the selection process.
Risk factors for primary POP
The articles investigating potential risk factors for primary
POP are listed in Table 1. Of the 10 articles included, 7 were
cross-sectional studies and 3 were prospective cohort studies.
Overall, the quality of the studies included was assessed as
adequate: all studies had clear participant recruitment and se-
lection criteria; the outcome and covariates were clearly de-
fined; the results were well presented; sample sizes were suf-
ficient for the number of predictor variables examined (i.e.,
more than 10 events per candidate variable) [12]. In 3 studies
it was explicitly described that the examining physician was
blinded to other data, such as a questionnaire or ultrasound
findings [6, 13, 14].
The 10 articles included enrolled a total of 41,501 women.
POP was defined as POPQ stage 2 or more in 4 studies [6,
14–16], as the most dependent point of the vaginal wall to or
beyond the hymenal remnants in 3 studies [17–19], as degree
2 or 3 of the Baden–Walker classification system in 1 study
[20], as the most dependent point of the vaginal wall to the
1560 Int Urogynecol J (2015) 26:1559–1573
introitus or outside of the vagina (according to the Women’s
Health Initiative classification system) in 1 study [21], and as
the most dependent point of the vaginal wall –0.5 cm above
the hymenal remnants in 1 study [13].
In the 10 articles, 30 potential risk factors were investigat-
ed, of which 17 were significantly associated with primary
POP at least once in themultivariate analysis. Obstetric factors
are represented in Table 2. Other potential risk factors are
shown in Table 3.
Risk factors for POP recurrence
The articles investigating potential risk factors for prolapse
recurrence are listed in Table 4. Of the 5 articles included, 3
were prospective cohort studies and 2 were retrospective co-
hort studies. Overall, the quality of the studies included was
assessed as adequate: all studies had clear participant recruit-
ment and selection criteria; the outcome and covariates were
clearly defined; results were well presented; median follow-up
after surgery was between 1 and 12 years. However, selective
loss to follow-up could not be excluded in 1 study, in which
less than half of the women included had attended the follow-
up visit and no comparisons were reported between women
attending the follow-up visit and women not attending the
follow-up visit [22]. In 4 out of 5 studies the number of risk
factors evaluated was higher than generally advised (i.e., 10
events per candidate variable) [12, 23–26]. For example, 1
study had 36 events (i.e., prolapse recurrence) and assessed
10 candidate variables [23], and another study had 42 events
and assessed 12 candidate variables [24]. In 1 study it was
explicitly described that the examining physician was blinded
to other data, such as a questionnaire or ultrasound findings
[25].
The 5 articles included enrolled a total of 954 women of
which 316 with POP recurrence. POP recurrence was defined
as POPQ stage 2 or more in all studies.
In the 5 articles, 29 potential risk factors were investigated,
of which 8 were significantly associated at least once with
POP recurrence after surgery in the multivariate analysis
(Table 5).
Risk factors discussed by topic
Obstetric factors
Parity and vaginal delivery were frequently investigated and
shown to be risk factors for primary POP [15, 16, 18–21],
except in 2 studies [6, 13]. The association with cesarean
delivery was less clear. While in 2 studies no association be-
tween cesarean delivery and primary POP was found [19, 20],
No physical exaination
Search Pubmed: 2,988
Selection of abstracts by two
independent reviewers: 130
Assessment with inclusion 
and exclusion form: 15
Articles on risk factors 
of primary prolapse: 10
Articles on risk factors 
of prolapse recurrence: 5
Removal of duplicates: 5,093
Search Embase: 4,449
Selection on title: 534
Reference check: 0
Exclusion because: 
- no multivariable analysis or insufficient data: 48
- insufficient definition of prolapse: 21
- no cohort or cross-sectional study: 19
- pelvic floor dysfunction in general: 6
- unclear if prolapse was primary or recurrence: 5
- review with primary studies already included: 5
- prolapse after mesh surgery: 3
- not about risk factors for prolapse: 3
- non-Western population: 2
- conference paper: 2
- follow-up less than one year: 1
Eligible for inclusion: 15
Exclusion because:
- not about risk factors for prolapse: 143
- no clinical research: 89
- pelvic floor dysfunction in general: 59
- conference paper, editors comments etc.: 56 
- prolapse after mesh surgery: 45 
- non-Western population: 7 
- animal study: 3
- duplicates (missed in the first removal): 2
Fig. 1 Flow diagram of the
selection process
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1 study showed that cesarean delivery was a risk factor when
compared with nulliparous women [16], and 2 studies found
that it was protective when compared with spontaneous or
operative vaginal delivery [17, 18]. There was a trend toward
an association between larger birth weight and primary POP,
but only in 1 out of 3 studies was this statistically significant
[13, 15, 20]. Higher age at first delivery was a risk factor in 1
study [18], but in another study no significant association was
found [15]. Operative vaginal delivery, age at last delivery,
and gravidity were investigated only once and no significant
associations were found, except for forceps delivery, which
was protective against primary POP when compared with
spontaneous vaginal delivery only [13, 15, 18].
For POP recurrence, parity and complicated delivery were
not significant risk factors [23–25]. This was in contrast with
primary POP, for which parity was a risk factor. This phenom-
enon might be because in studies concerning POP recurrence,
only women with a primary POP are included; therefore, this
is a selected group of women. Birth weight and age at last
delivery were only investigated once and no significant asso-
ciation was found [23, 24].
Lifestyle factors
Higher body mass index (BMI) as a categorical variable was a
significant risk factor for primary POP [13, 16, 20, 21], except
for the 2 studies with the smallest sample sizes [15, 18]. Two
studies investigated BMI as a continuous variable, of which 1
found no association [6] and in contrast with the other studies,
1 found that a higher BMI was slightly protective [19]. Waist
circumference and use of hormone replacement therapy were
each only once significantly associated with primary POP;
thus, no conclusion can be drawn [13, 15, 21]. The results
for the relation between smoking and primary POP were in-
consistent. One study showed a trend toward a positive asso-
ciation [20], while in 3 studies smoking was protective [6, 19,
21], and in 2 studies no association was found [13, 15]. One
study argued that there might be an association between cig-
arette smoking and POP because smoking causes chronic re-
spiratory diseases and higher abdominal pressure, but a nega-
tive association was found because smoking seemed to be
linked to factors such as age and menopausal status [19]. This
hypothesis was supported by the fact that in another study the
seemingly protective effect disappeared in the multivariate
analysis [13]. Physical activity was not a significant risk factor
for primary POP [6, 15, 21].
Although higher BMI was a risk factor for primary POP, it
was not a significant risk factor for POP recurrence [23–26].
Weight, intense physical exercise, heavy lifting, and smoking
were examined only once and only weight was significantly
associated with POP recurrence, but no firm conclusions can
be drawn owing to a lack of confirmation [24, 26].Ta
bl
e
2
(c
on
tin
ue
d)
R
is
k
fa
ct
or
T
im
es
in
ve
st
ig
at
ed
T
im
es
st
at
is
tic
al
ly
si
gn
if
ic
an
t
N
D
ef
in
iti
on
A
dj
us
te
d
O
R
a
(9
5
%
C
I)
R
ef
er
en
ce
27
0
>
3,
69
0
g
vs
≤3
,6
90
g
N
S
b
[1
5]
1,
00
4
Pe
r
10
ou
nc
es
O
R
1.
1
(1
.0
–1
.2
)*
[1
3]
A
ge
at
fi
rs
td
el
iv
er
y
2
1
27
0
<
20
vs
20
–2
4
vs
≥2
5
N
S
b
[1
5]
72
6
25
–2
9
vs
≤2
4
O
R
1.
5
(0
.9
–2
.3
)
[1
8]
30
–3
4
vs
≤2
4
O
R
2.
5
(1
.5
–4
.2
)*
≥3
5
vs
≤2
4
O
R
3.
1
(1
.4
–6
.6
)*
A
ge
at
la
st
de
liv
er
y
1
0
27
0
≤2
9
vs
30
–3
4
vs
≥3
5
N
Sb
[1
5]
G
ra
vi
di
ty
1
0
1,
00
4
Pe
r
1
O
R
0.
9
(0
.7
–1
.2
)
[1
3]
N
nu
m
be
r
of
pa
rt
ic
ip
an
ts
,O
R
od
ds
ra
tio
,9
5
%
C
I
95
%
co
nf
id
en
ce
in
te
rv
al
,P
R
pr
ev
al
en
ce
ra
tio
,R
R
ri
sk
ra
tio
,H
R
ha
za
rd
ra
tio
,N
S
no
ts
ta
tis
tic
al
ly
si
gn
if
ic
an
t
*S
ta
tis
tic
al
ly
si
gn
if
ic
an
ta
ss
oc
ia
tio
n
(p
<
0.
05
)
a
In
so
m
e
st
ud
ie
s
PR
,R
R
or
H
R
w
as
us
ed
b
N
o
ot
he
r
da
ta
in
ar
tic
le
1564 Int Urogynecol J (2015) 26:1559–1573
T
ab
le
3
N
on
-o
bs
te
tr
ic
ri
sk
fa
ct
or
s
fo
r
pr
im
ar
y
pr
ol
ap
se
R
is
k
fa
ct
or
T
im
es
in
ve
st
ig
at
ed
T
im
es
si
gn
if
ic
an
tly
di
ff
er
en
t
N
D
ef
in
iti
on
A
dj
us
te
d
O
R
a
(9
5
%
C
I)
R
ef
er
en
ce
L
if
es
ty
le
fa
ct
or
s
B
M
I
8
5
21
,4
49
23
.8
–2
7.
2
vs
<
23
.8
O
R
1.
6
(1
.2
–2
.2
)*
[2
0]
>
27
.2
vs
<
23
.8
O
R
1.
8
(1
.3
–2
.4
)*
27
0
<
27
vs
≥2
7
N
Sb
[1
5]
1,
00
4
25
–3
0
vs
<
25
O
R
2.
5
(1
.2
–5
.4
)*
[1
3]
>
30
vs
<
25
O
R
2.
6
(1
.2
–5
.4
)*
1,
13
7
25
–3
0
vs
<
25
PR
1.
1
(1
.0
–1
.1
)*
[1
6]
≥3
0
vs
<
20
PR
1.
1
(1
.0
–1
.1
)*
64
9
Pe
r
kg
/m
2
N
Sb
,c
[6
]
12
,6
50
25
–3
0
vs
<
25
H
R
1.
3
(1
.1
–1
.4
)*
[2
1]
≥3
0
vs
<
25
H
R
1.
3
(1
.1
–1
.5
)*
72
6
<
18
.5
vs
18
.5
–2
4.
9
O
R
1.
2
(0
.3
–5
.0
)
[1
8]
25
–2
9.
9
vs
18
.5
–2
4.
9
O
R
1.
3
(0
.9
–2
.0
)
≥3
0
vs
18
.5
–2
4.
9
O
R
1.
5
(0
.9
–2
.4
)
1,
96
4
Pe
r
kg
/m
2
O
R
1.
0
(0
.9
–1
.0
)*
[1
9]
Sm
ok
in
g
6
3
21
,4
49
<
10
vs
no
O
R
1.
6
(1
.0
–2
.6
)
[2
0]
10
–2
0
vs
no
O
R
1.
1
(0
.6
–2
.1
)
>
20
vs
no
O
R
1.
3
(0
.7
–2
.4
)
27
0
U
nk
no
w
n
N
Sb
,c
[1
5]
1,
00
4
E
ve
r
vs
ne
ve
r
O
R
1.
2
(0
.6
–2
.4
)
[1
3]
C
ur
re
nt
vs
ne
ve
r
O
R
0.
9
(0
.3
–2
.5
)
64
9
C
ur
re
nt
vs
no
O
R
0.
5
(0
.3
–0
.8
)*
[6
]
12
,6
50
Pa
st
vs
ne
ve
r
H
R
0.
8
(0
.7
–0
.8
)*
[2
1]
C
ur
re
nt
vs
ne
ve
r
H
R
0.
5
(0
.4
–0
.7
)*
1,
96
4
Y
es
vs
no
O
R
0.
6
(0
.3
–0
.9
)*
[1
9]
H
R
T
3
1
27
0
U
nk
no
w
n
N
Sb
,c
[1
5]
1,
00
4
E
ve
r
vs
ne
ve
r
O
R
1.
0
(0
.6
–1
.7
)
[1
3]
12
,6
50
E
+
P
tr
ea
tm
en
tv
s
pl
ac
eb
o
H
R
1.
1
(1
.0
–1
.3
)*
[2
1]
Pa
st
ho
rm
on
e
us
e
vs
ne
ve
r
H
R
1.
1
(1
.0
–1
.2
)
C
ur
re
nt
ho
rm
on
e
us
e
vs
ne
ve
r
H
R
1.
2
(1
.0
–1
.5
)
Ph
ys
ic
al
ac
tiv
ity
3
0
27
0
M
ild
vs
m
od
er
at
e
vs
st
re
nu
ou
s
N
Sb
,c
[1
5]
64
9
C
ur
re
nt
he
av
y
w
or
k
vs
no
O
R
1.
3
(0
.9
–2
.0
)
[6
]
Pa
st
he
av
y
w
or
k
vs
no
N
Sb
,c
12
,6
50
U
nk
no
w
n
H
R
1.
0
(1
.0
–1
.0
)
[2
1]
W
ai
st
ci
rc
um
fe
re
nc
e
2
1
27
0
<
88
cm
vs
≥8
8
cm
N
Sb
[1
5]
12
,6
50
>
88
cm
vs
<
88
cm
H
R
1.
2
(1
.0
–1
.4
)*
[2
1]
U
nm
od
if
ia
bl
e
fa
ct
or
s
A
ge
6
4
21
,4
49
52
–5
5
vs
≤5
1
O
R
1.
5
(1
.1
–2
.0
)*
[2
0]
≥5
6
vs
≤5
1
O
R
2.
6
(2
.0
–3
.4
)*
27
0
≥6
8
vs
<
68
N
S
b
,c
[1
5]
1,
00
4
Pe
r
10
ye
ar
s
O
R
1.
4
(1
.1
–1
.8
)*
[1
3]
1,
13
7
Pe
r
10
ye
ar
s
PR
1.
0
(1
.0
–1
.1
)*
[1
6]
Int Urogynecol J (2015) 26:1559–1573 1565
T
ab
le
3
(c
on
tin
ue
d)
R
is
k
fa
ct
or
T
im
es
in
ve
st
ig
at
ed
T
im
es
si
gn
if
ic
an
tly
di
ff
er
en
t
N
D
ef
in
iti
on
A
dj
us
te
d
O
R
a
(9
5
%
C
I)
R
ef
er
en
ce
64
9
Pe
r
1
ye
ar
N
Sb
,c
[6
]
12
,6
50
Pe
r
1
ye
ar
H
R
1.
0
(1
.0
–1
.0
)*
[2
1]
E
th
ni
ci
ty
3
2
1,
00
4
B
la
ck
vs
w
hi
te
O
R
1.
2
(0
.4
–3
.3
)
[1
3]
H
is
pa
ni
c
vs
w
hi
te
O
R
4.
3
(1
.8
–1
0.
2)
*
O
th
er
vs
w
hi
te
O
R
2.
4
(0
.5
–1
2.
1)
1,
13
7
W
hi
te
vs
A
fr
ic
an
–A
m
er
ic
an
PR
1.
0
(1
.0
–1
.1
)
[1
6]
A
si
an
vs
A
fr
ic
an
–A
m
er
ic
an
PR
1.
0
(1
.0
–1
.1
)
L
at
in
a/
ot
he
r
vs
A
fr
ic
an
–A
m
er
ic
an
PR
1.
0
(1
.0
–1
.1
)
12
,6
50
B
la
ck
vs
w
hi
te
H
R
0.
5
(0
.4
–0
.7
)*
[2
1]
H
is
pa
ni
c
vs
w
hi
te
H
R
0.
9
(0
.7
–1
.1
)
M
en
op
au
sa
ls
ta
tu
s
3
1
1,
00
4
N
o
vs
ye
s
O
R
0.
6
(0
.4
–1
.1
)c
[1
3]
64
9
Y
es
vs
no
O
R
1.
3
(0
.9
–1
.9
)
[6
]
1,
96
4
Y
es
vs
no
O
R
5.
2
(3
.4
–8
.0
)*
[1
9]
Fa
m
ily
hi
st
or
y
2
0
27
0
Fa
m
ily
w
ith
pr
ol
ap
se
/U
I
su
rg
er
y
N
S
b
,c
[1
5]
64
9
M
ot
he
r
w
ith
pr
ol
ap
se
vs
no
O
R
1.
6
(1
.0
–2
.4
)
[6
]
A
ge
at
m
en
op
au
se
1
0
21
,4
49
49
–5
1
vs
<
48
O
R
0.
9
(0
.7
–1
.3
)
[2
0]
≥5
2
vs
<
48
O
R
1.
1
(0
.8
–1
.5
)
A
ge
at
m
en
ar
ch
e
1
0
21
,4
49
12
–1
3
vs
<
11
O
R
0.
8
(0
.6
–1
.0
)
[2
0]
≥1
4
vs
<
11
O
R
1.
0
(0
.8
–1
.3
)
C
om
or
bi
di
ty
U
ri
na
ry
in
co
nt
in
en
ce
2
1
64
9
U
I
su
rg
er
y
vs
no
O
R
2.
2
(0
.9
–5
.4
)
[6
]
12
,6
50
St
re
ss
U
I
vs
ne
ve
r
H
R
1.
1
(1
.0
–1
.3
)
[2
1]
U
rg
e
U
I
vs
ne
ve
r
H
R
1.
3
(1
.1
–1
.5
)*
M
ix
ed
U
I
vs
ne
ve
r
H
R
1.
2
(1
.0
–1
.5
)*
O
th
er
U
I
vs
ne
ve
r
H
R
1.
0
(0
.8
–1
.4
)
Pu
lm
on
ar
y
di
se
as
e
2
0
27
0
A
st
hm
a
ye
s
vs
no
N
Sb
,c
[1
5]
12
,6
50
A
st
hm
a
H
R
1.
0
(0
.8
–1
.2
)
[2
1]
E
m
ph
ys
em
a
H
R
1.
2
(0
.9
–1
.6
)
C
on
st
ip
at
io
n
2
0
1,
00
4
Y
es
vs
no
N
S
c,
d
[1
3]
12
,6
50
M
od
er
at
e/
se
ve
re
vs
no
H
R
1.
0
(0
.8
–1
.2
)
[2
1]
D
ia
be
te
s
1
1
1,
13
7
Y
es
vs
no
PR
1.
1
(1
.1
–1
.1
)*
[1
6]
C
hr
on
ic
ill
ne
ss
1
0
1,
00
4
A
ny
vs
no
ne
O
R
1.
1
(0
.5
–2
.1
)c
[1
3]
H
ys
te
re
ct
om
y
st
at
us
1
0
1,
00
4
Y
es
vs
no
O
R
1.
1
(0
.7
–1
.6
)c
[1
3]
Pr
ev
io
us
he
rn
ia
su
rg
er
y1
0
27
0
Y
es
vs
no
N
Sb
,c
[1
5]
PO
P
in
pr
eg
na
nc
y
1
0
64
9
Y
es
vs
no
O
R
1.
4
(1
.0
–2
.1
)
[6
]
So
ci
al
fa
ct
or
s
E
du
ca
tio
n
4
2
21
,4
49
In
te
rm
ed
ia
te
sc
ho
ol
vs
el
em
en
ta
ry
O
R
0.
6
(0
.5
–0
.8
)*
[2
0]
H
ig
h
sc
ho
ol
/u
ni
ve
rs
ity
vs
el
em
en
ta
ry
O
R
0.
6
(0
.4
–0
.8
)*
27
0
≤H
ig
h
sc
ho
ol
vs
>
hi
gh
sc
ho
ol
O
R
2.
2
(1
.1
–4
.2
)*
[1
5]
1,
13
7
≥C
ol
le
ge
vs
<
co
lle
ge
PR
1.
0
(1
.0
–1
.1
)
[1
6]
64
9
In
te
rm
ed
ia
te
sc
ho
ol
vs
un
kn
ow
n
O
R
0.
7
(0
.4
–1
.1
)
[6
]
1566 Int Urogynecol J (2015) 26:1559–1573
Unmodifiable factors
Age was a risk factor for primary POP [13, 16, 20, 21],
except in the 2 smallest studies [6, 15]. The role of eth-
nicity remained unclear in relation to primary POP. In 1
study a higher risk in Hispanic women compared with
white women was found, while in another study there
was no significant association [13, 21]. Another study
found a higher risk in white women compared with black
women, while 2 other studies found no association [13,
16, 21]. Menopausal status showed a trend toward a pos-
itive association with primary POP, but in only 1 of the 3
studies was it a significant risk factor [6, 13, 19]. Family
history was not a significant risk factor [6, 15]. Age at
menopause and age at menarche were only examined once
and showed no association [20].
Age as a risk factor for POP recurrence showed inconsis-
tent results. In 2 studies, in which age was categorized as
below 60 years compared with 60 years or older, younger
age was a significant risk factor for POP recurrence after sur-
gery [22, 24]. In 2 studies in which age was a continuous
variable and in 1 study in which age was categorized as older
than 70 years compared with 70 years or younger, no signif-
icant associations were found [23, 25, 26]. With regard to
family history, 1 study found a significant association while
another found no significant association [24, 25]. Menopausal
status was not significantly associated with POP recurrence
[22, 23].
Comorbidity
Constipation and pulmonary disease were not significant-
ly associated with primary POP [13, 15, 21]. Urge and
mixed urinary incontinence showed a significant associa-
tion, while urinary incontinence surgery, stress urinary
incontinence, and other forms of urinary incontinence
were not significantly associated with primary POP [6,
21]. Diabetes mellitus, chronic illness, hysterectomy sta-
tus, previous hernia surgery, and POP in pregnancy were
examined once and only diabetes mellitus was significant-
ly associated with primary POP [13, 15, 16, 21]. Owing
to a lack of confirmation, no firm conclusions can be
drawn.
Regarding POP recurrence, previous pelvic floor surgery
and any preoperative urinary incontinence showed inconsis-
tent results [22, 25, 26]. Constipation, pulmonary disease, and
previous hysterectomy were not significant risk factors
[22–26]. Incomplete bladder emptying, fecal incontinence,
diabetes mellitus, and abdominal hernias were only investigat-
ed once and no significant associations were found [22, 24,
26]. Owing to a lack of confirmation, no firm conclusions can
be drawn.Ta
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Social factors
Having less education was a significant risk factor for primary
POP in 2 out of 4 studies, while occupation was not signifi-
cantly related [6, 13, 15, 16, 20]. Income was only investigat-
ed once [13]. Women with a medium income were less likely
to have POP compared with womenwith a high income, while
the number of women with POP in the low income group was
not significantly different from the number of women in the
high income group.
The relation between social factors and POP recurrence
was not evaluated in the 5 articles selected.
Pelvic floor factors
With regard to primary POP, levator defects and the genital
hiatus on transperineal ultrasound were investigated as risk
factors in 1 article [14]. Both a unilateral and a bilateral avul-
sion compared with no avulsion were significant risk factors
for primary POP. An increased hiatal area on Valsalva was
also associatedwith primary POP. For POP recurrence, levator
defects, the site of most advanced prolapse, the genital hiatus
on pelvic floor examination, and levator muscle contraction
on pelvic floor examination were examined in 1 report, and
only levator defects were significantly associated with POP
recurrence [22–25]. Because of a lack of confirmative studies,
no clear conclusion can be drawn.
Surgical factors
In 4 studies, preoperative stage 3 or 4 was a significant risk
factor for POP recurrence after surgery [22–25]. Only the
study in which preoperative stage 4 was compared with a
preoperative stage of less than 4 found no significant associ-
ation [26]. The number of sites involved preoperatively and
the surgeon’s experience were not significant risk factors for
POP recurrence [22, 24–26]. Concomitant surgery was exam-
ined in 1 article and a sacrospinous fixation was a significant
risk factor for POP recurrence [25].
Discussion
This systematic review provides an overview of the risk fac-
tors affecting the development of POP and POP recurrence
after native tissue repair, investigated in cohort studies and
cross-sectional studies. With regard to primary POP, parity,
vaginal delivery, age, and BMI were the most important risk
factors. Regarding POP recurrence, only preoperative stage
was a confirmed risk factor.
The differences between risk factors for primary POP and
POP recurrence might be explained by the differences in pop-
ulation. In studies concerning POP recurrence, only womenTa
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with a primary POP are included; thus, this is a selected group
of women. For instance, higher age was a risk factor for pri-
mary POP. If a woman obtained POP at a younger age, she
might be more prone to POP recurrence after surgery than an
older woman with POP, because of hereditary factors or con-
nective tissue weakness. Indeed, the studies investigating the
association between age and POP recurrence showed conflict-
ing results. Perhaps the association between age and POP
recurrence is not linear but parabolic, with both younger age
and higher age being risk factors for POP recurrence. This is
difficult to prove, but could explain the conflicting results.
Other causes of the differences in confirmed risk factors for
primary POP and POP recurrence might have been the smaller
number of studies and the smaller sample sizes in the evalua-
tion of risk factors for POP recurrence.
In the prevention of primary POP, BMI was the only
modifiable risk factor. Theoretically, parity and vaginal
delivery are also modifiable, but in obstetric care future
POP seldom plays a role in considerations. With regard
to preoperative counselling, only preoperative stage was
a confirmed risk factor in the estimation of the chance
of POP recurrence. The role of other patients' or sur-
geons’ characteristics was not confirmed.
There were several strengths and limitations of this review.
The search was thorough and systematic. Two reviewers in-
dependently carried out the study selection and data extraction
to minimize errors. Potential risk factors for both primary POP
and POP recurrence were studied. We extracted the results of
the multivariate analyses; thus, the reported effects were ad-
justed for potentially confounding variables. Studies with
follow-up after surgery of less than 1 year were excluded to
avoid bias due to surgical failures, which represents a different
phenomenon than POP recurrence.
Only studies situated in western developed countries
were included, because the population in developing
countries may differ from that in developed countries.
It has been stated that the prevalence of symptomatic
POP among women in developing countries is higher
than among women in developed countries, owing to
early childbearing, high parity, low birth spacing, early
return to work after delivery, poor birthing practices,
frequent heavy lifting, and malnutrition [27]. Many
women do not seek medical attention because of embar-
rassment, social taboos, fear of abandonment, knowl-
edge deficit, lack of resources, and lack of access to
trained personnel [28, 29].
Recurrence of POP was defined as anatomical recurrence
after native tissue repair, i.e., without the use of mesh mate-
rials. Native tissue repair is the standard method of POP sur-
gery, while the use of mesh in POP surgery has become con-
troversial [30]. It is stated that the use of mesh should be
reserved for high-risk individuals in whom the benefit of the
use of mesh may justify the risks, such as individuals with
recurrent POP [31]. The population in studies on POP recur-
rence after mesh surgery often consists of a selected, high-risk
group of women, which cannot be compared with the popu-
lation in studies on POP recurrence after native tissue repair.
Systematic reviews of prognostic studies are compli-
cated by several issues, which have been well described
by Altman [32]. Two major concerns are the quality of
the primary studies and the possibility of publication
bias. Although there is abundant literature to help re-
searchers perform this type of research, there are still
no widely agreed guidelines for assessing the quality
of prognostic studies and there is no standard approach
to building a multivariate prediction model [33]. Clear
guidelines on the assessment of the quality of this type
of study would be helpful.
Because of the enormous amount of available articles and
variables studied on this subject, we were forced to select the
papers providing the strongest evidence. We decided to ex-
clude case–control studies because they are more prone to
selection bias and often contain a smaller sample size than
cohort or cross-sectional studies. Risk factors that have only
been examined in case–control studies, such as collagen and
matrix metalloproteinase polymorphisms, have been missed
owing to this strategy.
Even after exclusion of case–control studies there
was heterogeneity among the available studies. For ex-
ample, the definitions of primary POP and the defini-
tions of risk factors varied widely between studies, di-
verse covariates were used in multivariate analyses, and
in the studies on POP recurrence there was diversity
among the surgery performed. Because of this heteroge-
neity, it was not possible to perform a meta-analysis to
pool the available results into reliable risk ratios. For
uniformity, only articles were included with a definition
of POP based on anatomical references such as the hy-
menal remnants or POPQ stage 2. POP recurrence was
defined as anatomical recurrence after surgery, but this
does not equate to recurrence or persistence of symp-
toms, which would have been a more patient-centered
outcome [34]. Many women who may be categorized as
Banatomical failuresB are, in fact, satisfied with their
postsurgical results [35]. The problem with studies using
only subjective findings for the definition of POP recur-
rence is that it is not possible to differentiate between
the recurrence of POP in the same operated vaginal
compartment and that in a different one [11]. That is
why only studies in which pelvic floor examination was
performed were included in this review. Uniformly ac-
cepted criteria for the definition of a successful POP
operation are still lacking [36].
Furthermore, there are inconsistencies among studies as to
whether a potential risk factor was indeed significantly asso-
ciated with the primary outcome. Some potential risk factors
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were even protective against the primary outcome in one
study, while they were a risk factor for that same outcome in
another study. This made it difficult to come to conclusions.
That is why we confirmed as risk factors only those that were
significantly associatedwith POP or POP recurrence in at least
two studies. Consequently, risk factors that have only been
studied once and were significantly associated with POP or
POP recurrence were not described as confirmed risk factors.
In conclusion, this systematic review showed that parity,
vaginal delivery, age, and BMI were confirmed risk factors for
the development of POP and that preoperative stage was a
confirmed risk factor for POP recurrence after native tissue
repair in western developed countries.
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Appendix A1: full PubMed literature search terms
((((pelvic prolapse[tiab] OR pelvic prolapses[tiab] OR
((((prolapse[tiab] OR prolapses[tiab]) AND (urogenital[tiab]
OR genital[tiab] OR vaginal[tiab] OR pelvic organ[tiab]) OR
cystocele[tiab] OR cystoceles[tiab] OR urinary bladder
prolapse[tiab] OR urinary bladder prolapses[tiab]))
OR rectocele OR rectoceles OR ("Pelvic Organ
Prolapse"[Mesh])))) AND ((((("Recurrence"[Mesh])) OR
(recurrence[tiab] OR recurrences[tiab] OR recurrent[tiab] OR
relapse[tiab] OR relapses[tiab]))) OR (relapsing[tiab])))) OR
((("Risk Factors"[Mesh] OR risk[tiab] OR risks[tiab] OR "risk
factor"[tiab] OR "risk factors"[tiab] OR Bpredict^[tiab] OR
Bpredicts^[tiab] OR Bprediction^[tiab] OR Bpredictions^[tiab]
OR Bpredictive^[tiab] OR Bpredicting^[tiab])) AND (("Pelvic
Organ Prolapse"[Mesh]) OR ((prolapse[t iab] OR
prolapses[tiab]) AND (urogenital[tiab] OR genital[tiab] OR
vaginal[tiab] OR pelvic organ[tiab] OR pelvic[tiab]) OR
cystocele[tiab] OR cystoceles[tiab] OR urinary bladder
prolapse[tiab] OR urinary bladder prolapses[tiab])))
Appendix A2: full Embase literature search terms
((((pelvic prolapse[tiab] OR pelvic prolapses[tiab] OR
((((prolapse[tiab] OR prolapses[tiab]) AND (urogenital[tiab]
OR genital[tiab] OR vaginal[tiab] OR pelvic organ[tiab]) OR
cystocele[tiab] OR cystoceles[tiab] OR urinary bladder
prolapse[tiab] OR urinary bladder prolapses[tiab])) OR
r e c t o c e l e OR r e c t o c e l e s OR ( " P e l v i c O r g a n
Prolapse"[Mesh])))) AND ((((("Recurrence"[Mesh])) OR
(recurrence[tiab] OR recurrences[tiab] OR recurrent[tiab]
OR relapse[tiab] OR relapses[tiab]))) OR (relapsing[tiab]))))
OR ((("Risk Factors"[Mesh] OR risk[tiab] OR risks[tiab] OR
"risk factor"[tiab] OR "risk factors"[tiab] OR Bpredict^[tiab]
OR Bp red i c t s^[ t i ab ] OR Bp red i c t i on^[ t i ab ] OR
Bp r e d i c t i o n s^[ t i a b ] OR Bp r e d i c t i v e^[ t i a b ] OR
Bpredicting^[tiab])) AND (("Pelvic Organ Prolapse"[Mesh])
OR ( (p ro l apse [ t i ab ] OR pro l apse s [ t i ab ] ) AND
(urogenital[tiab] OR genital[tiab] OR vaginal[tiab] OR pelvic
organ[tiab] OR pelvic[tiab]) OR cystocele[tiab] OR
cystoceles[tiab] OR urinary bladder prolapse[tiab] OR urinary
bladder prolapses[tiab])))
Open Access This article is distributed under the terms of the Creative
Commons At t r ibut ion 4 .0 In te rna t ional License (h t tp : / /
creativecommons.org/licenses/by/4.0/), which permits unrestricted use,
distribution, and reproduction in any medium, provided you give appro-
priate credit to the original author(s) and the source, provide a link to the
Creative Commons license, and indicate if changes were made.
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